These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3214088)

  • 1. Synthesis and structure-activity correlations within allylamine antimycotics.
    Stütz A
    Ann N Y Acad Sci; 1988; 544():46-62. PubMed ID: 3214088
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.
    Stütz A; Georgopoulos A; Granitzer W; Petranyi G; Berney D
    J Med Chem; 1986 Jan; 29(1):112-25. PubMed ID: 3510297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of antifungal agents. Synthesis and antimycotic activity of disubstituted N-azolylamines.
    Castellano S; Stefancich G; Musiu C; La Colla P
    Arch Pharm (Weinheim); 2000 Sep; 333(9):299-304. PubMed ID: 11039186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of benzo[b]thienylallylamine antimycotics.
    Nussbaumer P; Petranyi G; Stütz A
    J Med Chem; 1991 Jan; 34(1):65-73. PubMed ID: 1992153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiophene congeners of morpholine and allylamine type antifungals--syntheses and biological activities.
    Bracher F; Papke T
    Pharmazie; 1995 Aug; 50(8):525-7. PubMed ID: 7568314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.
    Petranyi G; Ryder NS; Stütz A
    Science; 1984 Jun; 224(4654):1239-41. PubMed ID: 6547247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action and biochemical selectivity of allylamine antimycotic agents.
    Ryder NS
    Ann N Y Acad Sci; 1988; 544():208-20. PubMed ID: 3063168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trialkylamine Derivatives Containing a Triazole Moiety as Promising Ergosterol Biosynthesis Inhibitor: Design, Synthesis, and Antifungal Activity.
    Sui G; Zhang W; Zhou K; Li Y; Zhang B; Xu D; Zou Y; Zhou W
    Chem Pharm Bull (Tokyo); 2017; 65(1):82-89. PubMed ID: 28049918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers.
    Vargas M LY; Castelli MV; Kouznetsov VV; Urbina G JM; López SN; Sortino M; Enriz RD; Ribas JC; Zacchino S
    Bioorg Med Chem; 2003 Apr; 11(7):1531-50. PubMed ID: 12628677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole antifungal agents related to naftifine and butenafine.
    Castellano S; La Colla P; Musiu C; Stefancich G
    Arch Pharm (Weinheim); 2000 Jun; 333(6):162-6. PubMed ID: 10909187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of clinically important antifungal drugs.
    Kerridge D
    Adv Microb Physiol; 1986; 27():1-72. PubMed ID: 3532715
    [No Abstract]   [Full Text] [Related]  

  • 13. [Future of antifungal and antiviral agents. 1. Antifungal agents].
    Arai T
    Nihon Rinsho; 1984 Mar; 42(3):629-37. PubMed ID: 6381802
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationship study of homoallylamines and related derivatives acting as antifungal agents.
    Suvire FD; Sortino M; Kouznetsov VV; Vargas M LY; Zacchino SA; Cruz UM; Enriz RD
    Bioorg Med Chem; 2006 Mar; 14(6):1851-62. PubMed ID: 16289857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antifungal activities of natural and synthetic biflavonoids.
    Sagrera G; Bertucci A; Vazquez A; Seoane G
    Bioorg Med Chem; 2011 May; 19(10):3060-73. PubMed ID: 21530273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, spectral characterization, and in vitro antibacterial and antifungal activities of novel 1,3-thiazine-2-amines comprising morpholine nucleus.
    Thanusu J; Kanagarajan V; Gopalakrishnan M
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):756-64. PubMed ID: 20590407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Two Alternative Routes for the Synthesis of Naftifine and Analogues as Potential Antifungal Agents.
    Abonia R; Garay A; Castillo JC; Insuasty B; Quiroga J; Nogueras M; Cobo J; Butassi E; Zacchino S
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aliphatic amines as antipityrosporum agents.
    Dixon H; Van Abbé NJ; Sugden JK
    J Med Chem; 1972 Feb; 15(2):212-4. PubMed ID: 5008249
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis, spectral and biological evaluation of novel 1-allyl substituted 2,6-diphenylpiperidin-4-ones and its derivatives of oximes/oxime ethers.
    Narayanan K; Shanmugam M; Jothivel S; Kabilan S
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6602-7. PubMed ID: 23031593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of bile acid-based amino sterols as antimicrobial agents.
    Aher NG; Pore VS; Mishra NN; Shukla PK; Gonnade RG
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5411-4. PubMed ID: 19679476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.